(1 - 25 from 40
)
Company News - Biotechgate - Nordic Life Sciences Database
www.scandinavianlifesciences.com
... PD-(L)1 pathway inhibition, thus preventing T cells from attacking the cancer cells,” said Vito Palombella, chief scientific officer, Surface Oncology. › index.php
Infinity Enters into Agreement with Roche | Technology Networks
www.technologynetworks.com
4 Sept — ... play critical roles in the growth and survival of tumor cells,” stated Vito Palombella, Ph.D., chief scientific officer at Infinity. › News
Surface Oncology to Present at the Baird Global ...
www.einnews.com
3 Sept — ... today announced that Jeff Goater, chief executive officer, and Vito Palombella, Ph.D., chief scientific officer, will participate in a ... › pr_news › surface-oncolog...
Untitled
www.chinesebiotech.com
... PD-(L)1 pathway inhibition, thus preventing T cells from attacking the cancer cells,” said Vito Palombella, chief scientific officer, Surface Oncology. › gate › news_details
sorted by relevance / date